Latest Updates
February 2022
Duke University Hospital Finishes COVIAGE™ Study
Duke University Hospital has finished the study of COVIAGE™ study in the ICU.
COVIAGE™ Presented at the Southeastern Surgical Congress 2022 Annual Meeting and Showcased as the Finalist in the “Sharks“ Competition!
Our CEO presented the results from our testing of COVIAGE™ to a large group of surgeons and received overwhelmingly positive feedback from the audience and judges during the Sharks Competition modeled by the ABC’s Shark Tank!
Duke University Hospital Begins COVIAGE™ Study
Duke University Hospital has commenced COVIAGE™ studies in the medical ICU and are expected to complete Phase I of the study in the next few months. Stay updated to learn more!
October 2021
August 3, 2021
COVIAGE™ granted a patent by the United States Patent and Trademark Office
COVIAGE™ was granted a patent by the USPTO
Selected Featured Startup at Venture Connect 2021 Online Summit!
Venture Connect Online is a digital experience that is designed to maximize the visibility of your company and help you build relationships with people (investors, peers, customers, and/or partners) who can help you scale.
March 23-25, 2021
Featured Innovator for Annual Invented at Duke Event!
Invented at Duke celebrates and promotes the diverse accomplishments of Duke innovators and entrepreneurs. The event showcases select technologies, inventions, and novel ideas-illustrating the breadth of Duke discoveries-while also highlighting Duke's innovation and entrepreneurship resources and facilitating discussions among Duke inventors and the broader Duke community.
January 27, 2021
iSolace, Inc. officially incorporates!
November 2, 2020
FDA grants COVIAGE™ an Emergency Use Authorization (EUA)
Our first product, COVIAGE™, has received Emergency Use Authorization from the FDA. This allows us to begin clinical implementation of the COVIAGE™ in Duke University Hospitals.
September 24, 2020
Pediatric COVIAGE Receives Southwest National Pediatric Device Consortium (SWPDC) 2020 Impact Grant for COVID-19
Pediatric-COVIAGE is a child-friendly negative pressure isolation system being developed at Duke University that is designed to improve care for hospitalized SARS-CoV-2 positive children by enhancing the hospitalization experience and decreasing stress for children with COVID-19 required hospitalization. Further modifications are planned toward a positive pressure isolation system for immunocompromised children. (Award amount: $20,000)
August 31, 2020
Featured Articles and Publications
iSolace, Inc. and COVIAGE™ Patent updates featured in Duke Pratt School of Engineering News!
Duke’s Design Health teams are finding success, earning top spots in national design competitions and turning innovative prototypes into patents
April 2021
January 2021
New Jersey Press Release
Duke University Engineers and Physicians launch startup with the first FDA Emergency Use Authorized Negative Pressure Patient Isolation Tent to alleviate COVID-19 PPE shortage and protect healthcare providers.
September 2020
COVIAGE™ and CEO, Dr. Konstantinos Economopoulos featured in the Duke Biomedical Engineering Magazine
An interdisciplinary team of engineers, clinicians and other experts from across Duke came together to create medical devices and tools to address COVID-19